← back to database
Hatteras Venture Partners builds seed- and early-stage healthcare companies across biotechnology, medical technology, diagnostics, and health technology. It has managed more than $900 million and frequently serves as a founding, first institutional, or lead investor.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Investing team
Ben ScruggsPartner
Christy ShafferGeneral Partner
- Clay B. ThorpGeneral Partner
- Douglas ReedGeneral Partner
Graham SmithAssociate
- John CrumplerGeneral Partner
Kseniya SimpsonPartner
- Lauren P. FlickingerPartner & Fund Manager
Notable investments
CVRx, Kymera Therapeutics, G1 Therapeutics, HistoSonics, Clearside Biomedical, Shattuck Labs, Vigil Neuroscience